Vyome Holdings, Inc. (HIND)
1.80
+0.05
(+2.86%)
USD |
NASDAQ |
Oct 30, 16:00
1.78
-0.02
(-1.11%)
After-Hours: 20:00
Vyome Holdings Price : 1.80 for Oct. 30, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | 1.73 | 2.14 | 1.718 | 1.80 | 42194.00 |
| Oct 29, 2026 | 1.72 | 1.827 | 1.72 | 1.75 | 13155.00 |
| Oct 28, 2026 | 1.68 | 1.72 | 1.620 | 1.72 | 8065.00 |
| Oct 27, 2026 | 1.71 | 1.75 | 1.688 | 1.70 | 5030.00 |
| Oct 26, 2026 | 1.782 | 1.87 | 1.701 | 1.71 | 16715.00 |
| Oct 23, 2026 | 1.794 | 1.794 | 1.775 | 1.79 | 2253.00 |
| Oct 22, 2026 | 1.84 | 1.84 | 1.75 | 1.80 | 10869.00 |
| Oct 21, 2026 | 1.86 | 1.87 | 1.84 | 1.84 | 2235.00 |
| Oct 20, 2026 | 1.86 | 1.88 | 1.83 | 1.84 | 8246.00 |
| Oct 19, 2026 | 1.87 | 1.87 | 1.84 | 1.84 | 8952.00 |
| Oct 16, 2026 | 1.89 | 1.91 | 1.860 | 1.87 | 11238.00 |
| Oct 15, 2026 | 1.918 | 1.930 | 1.83 | 1.91 | 14989.00 |
| Oct 14, 2026 | 1.94 | 1.981 | 1.91 | 1.93 | 6355.00 |
| Oct 13, 2026 | 2.09 | 2.09 | 1.95 | 1.97 | 9961.00 |
| Oct 12, 2026 | 2.04 | 2.045 | 1.99 | 2.01 | 7054.00 |
| Oct 09, 2026 | 2.03 | 2.09 | 2.01 | 2.09 | 7585.00 |
| Oct 08, 2026 | 2.03 | 2.030 | 1.98 | 2.03 | 8004.00 |
| Oct 07, 2026 | 2.02 | 2.06 | 1.98 | 2.04 | 11375.00 |
| Oct 06, 2026 | 2.01 | 2.07 | 1.904 | 2.06 | 13740.00 |
| Oct 05, 2026 | 1.905 | 2.00 | 1.905 | 1.93 | 10164.00 |
| Oct 02, 2026 | 1.84 | 1.96 | 1.82 | 1.91 | 20223.00 |
| Oct 01, 2026 | 1.93 | 2.00 | 1.91 | 1.92 | 9003.00 |
| Sep 30, 2026 | 1.93 | 2.042 | 1.90 | 1.93 | 7490.00 |
| Sep 29, 2026 | 1.99 | 2.02 | 1.99 | 2.02 | 8579.00 |
| Sep 28, 2026 | 2.01 | 2.06 | 2.01 | 2.03 | 5143.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Cardiac Biotech Solutions, Inc. | 0.0305 |
| Anika Therapeutics, Inc. | 20.95 |
| Enovis Corp. | 19.91 |
| Edwards Lifesciences Corp. | 92.01 |
| Perspective Therapeutics, Inc. | 1.15 |
Price Related Metrics
| PS Ratio | 77.67 |
| Price to Book Value | 2.089 |
| Price to Free Cash Flow | 19.21 |
| Earnings Yield | -194.8% |
| Market Cap | 12.63M |